TY  - JOUR

T1  - Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study

JO  - PharmacoEconomics

UR  - http://eprints.whiterose.ac.uk/173442/

PY  - 2021/04/26

AU  - Pennington R

AU  - Alshreef A

AU  - Flight L

AU  - Metry A

AU  - Poku E

AU  - Hykin P

AU  - Sivaprasad S

AU  - Prevost AT

AU  - Vasconcelos JC

AU  - Murphy C

AU  - Kelly J et al

ED  - 

DO  - DOI: 10.1007/s40273-021-01026-5

PB  - Springer

Y2  - 2024/12/21

ER  -